[1] CHAI E Z,SHANMUGAM M K,ARFUSO F,et al.Targeting transcription factor STAT3 for cancer prevention and therapy[J].Pharmacology & Therapeutics,2016,162:86-97. [2] GARCIA R,JOVE R.Activation of STAT transcription factors in oncogenic tyrosine kinase signaling[J].Journal of Biomedical Science,1998,5(2):79-85. [3] SHI S,MA H Y,ZHANG Z G.Clinicopathological and prognostic value of STAT3/p-STAT3 in cervical cancer:A meta and bioinformatics analysis[J].Pathology-Research and Practice,2021,227:153624. [4] 陈越,季鸣,陈晓光.STAT3与肿瘤关系的研究进展[J].药学学报,2017,52(9):1351-1358. CHEN Y,JI M,CHEN X G.Research progress of relationship between STAT3 and tumor[J].Acta Pharmaceutica Sinica,2017,52(9):1351-1358.(in Chinese) [5] TOŠI AC'G I,FRANK D A.STAT3 as a mediator of oncogenic cellular metabolism:Pathogenic and therapeutic implications[J].Neoplasia,2021,23(12):1167-1178. [6] LEE H,JEONG A J,YE S K.Highlighted STAT3 as a potential drug target for cancer therapy[J]. BMB Reports,2019,52(7):415-423. [7] 赵辨.中国临床皮肤病学[M].第2版.南京:江苏科技技术出版社,2017. ZHAO B.Clinical Dermatology in China[M].2nd ed. Nanjing:Jiangsu Science and Technology Press,2017.(in Chinese) [8] GUO W,WANG H,LI C.Signal pathways of melanoma and targeted therapy[J].Signal Transduction and Targeted Therapy,2021,6(1):424. [9] PALMA S D,MCCONNELL A,VERGANTI S,et al.Review on canine oral melanoma:An undervalued authentic genetic model of human oral melanoma?[J].Veterinary Pathology,2021,58(5):881-889. [10] 毛爱迪,陈爱军,王萍.恶性黑色素瘤治疗最新研究进展[J].重庆医学,2021,50(20):3581-3585. MAO A D,CHEN A J,WANG P.Recent research progress in the treatment of malignant melanoma[J].Chongqing Medicine,2021,50(20):3581-3585.(in Chinese) [11] 王永芳,谭谦.皮肤恶性黑色素瘤诊断和外科治疗的研究进展[J].东南大学学报(医学版),2021,40(5):721-725. WANG Y F,TAN Q.Research progress in the diagnosis and surgical treatment of cutaneous malignant melanoma[J].Journal of Southeast University (Medical Science Edition),2021,40(5):721-725.(in Chinese) [12] HAMERS-CASTERMAN C,ATARHOUCH T,MUYLDERMANS S,et al.Naturally occurring antibodies devoid of light chains[J].Nature,1993,363(6428):446-448. [13] HARMSEN M M,RUULS R C,NIJMAN I J,et al.Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features[J].Molecular Immunology,2000,37(10):579-590. [14] LI C,TANG Z,HU Z,et al.Natural single-domain antibody-nanobody:A novel concept in the antibody field[J].Journal of Biomedical Nanotechnology,2018,14(1):1-19. [15] SALVADOR J P,VILAPLANA L,MARCO M P.Nanobody:Outstanding features for diagnostic and therapeutic applications[J].Analytical and Bioanalytical Chemistry,2019,411(9):1703-1713. [16] VERHAAR E R,WOODHAM A W,PLOEGH H L.Nanobodies in cancer[J]. Seminars in Immunology,2021,52:101425. [17] BAO G,TANG M,ZHAO J,et al.Nanobody:A promising toolkit for molecular imaging and disease therapy[J].EJNMMI Research,2021,11(1):6. [18] 吕巧,邹超霞,吴永梅,等.STAT3基因对广西黄牛肌肉干细胞成肌诱导分化的调控研究[J].中国畜牧兽医,2021,48(8):2771-2777. LYU Q,ZOU C X,WU Y M,et al.Study on regulation of STAT3 gene on myogenic differentiation of muscle stem cells in Guangxi cattle[J].China Animal Husbandry & Veterinary Medicine,2021,48(8):2771-2777.(in Chinese) [19] YU H,KORTYLEWSKI M,PARDOLL D.Crosstalk between cancer and immune cells:Role of STAT3 in the tumour microenvironment.[J].Nature Reviews Immunology,2007,7(1):41-51. [20] MITCHELL L S,COLWELL L J.Comparative analysis of nanobody sequence and structure data[J].Proteins Structure Function & Genetics,2018,86(7):697-706. [21] ZAVRTANIK U,LUKAN J,LORIS R,et al.Structural basis of epitope recognition by heavy-chain camelid antibodies [J].Journal of Molecular Biology,2018,430(21):4369-4386. [22] SUN S,DING Z,YANG X, et al.Nanobody:A small antibody with big implications for tumor therapeutic strategy[J].International Journal of Nanomedicine,2021,16:2337-2356. [23] 李宏芬,单保恩,陈晶,等.抗Stat3多克隆抗体的制备和其在乳腺癌诊断中的应用[J].第四军医大学学报,2006,27(24):2242-2244. LI H F,SHAN B E,CHEN J,et al.Preparation of polyclonal antibody against STAT3 and its application in the diagnosis of breast cancer[J]. Journal of the Fourth Military Medical University,2006,27(24):2242-2244.(in Chinese) [24] 严昊,冯建远,张子仪,等.纳米抗体的制备与临床应用研究进展[J].中国畜牧兽医,2021,48(2):685-694. YAN H,FENG J Y,ZHANG Z Y,et al.Progress in preparation and clinical application of nanobody[J].China Animal Husbandry & Veterinary Medicine,2021,48(2):685-694.(in Chinese) [25] MOHASSAB A M,HASSAN H A,ABDELHAMID D,et al.STAT3 transcription factor as target for anti-cancer therapy[J].Pharmacological Reports,2020,72(5):1101-1124. [26] SIVEEN K S,SIKKA S,SURANA R,et al.Targeting the STAT3 signaling pathway in cancer:Role of synthetic and natural inhibitors[J]. Biochimica et Biophysica Acta,2014,1845(2):136-154. [27] AL ZAID SIDDIQUEE K,TURKSON J.STAT3 as a target for inducing apoptosis in solid and hematological tumors[J].Cell Research,2008,18(2):254-267. [28] LIN L,DEANGELIS S,FOUST E,et al.A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells[J].Molecular Cancer,2010,9(1):217. |